Internal Medicine 1223 - Internal Medicine Alert - Dec 15, 2008

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Joseph E. Scherger, MD, MPH
Clinical Professor, University of California
San Diego

Mary Elina Ferris, MD

Clinical Associate Professor
University of Southern California

Harold L. Karpman, MD, FACC, FACP

Clinical Professor of Medicine
UCLA School of Medicine

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Ken Grauer, MD
Professor, Assistant Director
Family Practice Residency
Program, University of Florida

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • Reshuffling the Medication Choices for Type 2 Diabetes
  • Hip Fractures Associated with Low Vitamin D
  • Does Ezetimibe Cause Cancer?
  • Colesevelam Hydrochloride Tablets (Welchol√ɬ§): Use in Type 2 Diabetes Mellitus
  • Clinical Briefs by Louis Kuritzky, MD
  • ECG Review: Having New Chest Pain or Not?

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, is a consultant for Abbott, Amylin, Boehringer Ingelheim, Eli Lilly, Endo, Novartis, and Novo Nordisk. Associate editors Joseph E. Scherger, MD, MPH,, Mary Elina Ferris, MD, and Harold L. Karpman, MD, FACC, FACP, and peer reviewer Gerald Roberts, MD, report no financial relationship to this field of study. Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker's bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim. Associate editor Ken Grauer, MD is the sole proprietor of KG-EKG Press, and publisher of an ECG pocket brain book.

Copyright 2008 AHC Media. All rights reserved.